This study was undertaken to determine virus removal efficiency by iron coagulation followed by microfiltration (MF) in water treatment using the MS2 bacteriophage (approximately 25 nm diameter) as a tracer virus. Results from these bench-scale studies were used to propose a mechanism for virus removal by iron coagulation-MF. Ferric chloride was used as coagulant, and the dosages were 0, 2, 5, and 10 mg/L as Fe(III) with pH adjusted during mixing to 6.3, 7.3 and 8.3. In the absence of iron-coagulation and with less than 2 mg/L Fe, MF alone achieved less than a 0.5 log removal of MS2 virus. However, iron-coagulation pretreatment dramatically improved virus removal, especially in the 5-10 mg/L Fe dose range, ultimately achieving more than 4-log removal at pH 6.3 with 10-mg/L Fe dose. For the 5 and 10 mg/L Fe dosages, decreasing pH in the 8.3-6.3 range resulted in significantly greater virus removal. For 0 and 2 mg/L iron dosages, decreasing pH in the 8.3-6.3 range also improved virus removal, but to a lesser extent. The experimental data indicates negatively charged MS2 viruses first adsorbed onto the positively charged iron oxyhydroxide floc particles before being removed by MF. MS2 viruses were not inactivated in iron or aluminum coagulation as evidenced by the fact that their concentrations before and after coagulation, settling, and re-suspension of the coagulated sludge were not statistically different.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.watres.2005.09.035 | DOI Listing |
Virol J
January 2025
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Infection with Influenza A virus (IAV) induces severe inflammatory responses and lung injury, contributing significantly to mortality and morbidity rates. Alterations in the microbial composition of the lungs and intestinal tract resulting from infection could influence disease progression and treatment outcomes. Xiyanping (XYP) injection has demonstrated efficacy in clinical treatment across various viral infections.
View Article and Find Full Text PDFMethods Enzymol
January 2025
Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu, P.R. China. Electronic address:
As a promising therapeutic approach, the RNA editing process can correct pathogenic mutations and is reversible and tunable, without permanently altering the genome. RNA editing mediated by human ADAR proteins offers unique advantages, including high specificity and low immunogenicity. Compared to CRISPR-based gene editing techniques, RNA editing events are temporary, which can reduce the risk of long-term unintended side effects, making off-target edits less concerning than DNA-targeting methods.
View Article and Find Full Text PDFPLoS Pathog
January 2025
Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
We have demonstrated that the cellular protein M-Sec promotes the transmission of human T-cell leukemia virus type 1 (HTLV-1) in vitro and in vivo. Here, we show how HTLV-1 utilizes M-Sec for its efficient transmission. HTLV-1-infected CD4+ T cells expressed M-Sec at a higher level than uninfected CD4+ T cells.
View Article and Find Full Text PDFJ Infect Dev Ctries
December 2024
Intensive Care Unit, Columbia Asia Hospital, Semarang, Indonesia.
Introduction: Hemoperfusion (HP), a blood filtration method targeting the removal of toxins and inflammatory elements, was investigated in this study. The objective was to present the observations in four individuals with confirmed COVID-19 who underwent several rounds of HP utilizing the HA330 cartridge at a hospital in Indonesia.
Case Studies: We report four cases of COVID-19 patients who underwent HP.
Viruses
January 2025
Service des Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière, APHP Sorbonne Université, 75013 Paris, France.
Phage therapy is experiencing renewed interest, particularly for antibiotic-resistant infections, and may also be useful for difficult-to-treat cases where surgery to remove foreign infected material is deemed too risky. We report a case of recurrent endocarditis with Bentall infection treated successfully with a combination of antibiotics and phages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!